168 related articles for article (PubMed ID: 32774656)
1. Cervical cancer screening behaviours and challenges: a sub-Saharan Africa perspective.
Anaman-Torgbor J; Angmorterh SK; Dordunoo D; Ofori EK
Pan Afr Med J; 2020; 36():97. PubMed ID: 32774656
[TBL] [Abstract][Full Text] [Related]
2. Drivers of cervical cancer prevention and management in sub-Saharan Africa: a qualitative synthesis of mixed studies.
Atnafu DD; Khatri R; Assefa Y
Health Res Policy Syst; 2024 Feb; 22(1):21. PubMed ID: 38331830
[TBL] [Abstract][Full Text] [Related]
3. Opportunities and challenges for introducing HPV testing for cervical cancer screening in sub-Saharan Africa.
Tsu VD; Njama-Meya D; Lim J; Murray M; de Sanjose S
Prev Med; 2018 Sep; 114():205-208. PubMed ID: 30031013
[TBL] [Abstract][Full Text] [Related]
4. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
5. Interventions to increase uptake of cervical screening in sub-Saharan Africa: a scoping review using the integrated behavioral model.
Lott BE; Trejo MJ; Baum C; McClelland DJ; Adsul P; Madhivanan P; Carvajal S; Ernst K; Ehiri J
BMC Public Health; 2020 May; 20(1):654. PubMed ID: 32393218
[TBL] [Abstract][Full Text] [Related]
6. Health care access dimensions and cervical cancer screening in South Africa: analysis of the world health survey.
Akinyemiju TF; McDonald JA; Lantz PM
BMC Public Health; 2015 Apr; 15():382. PubMed ID: 25886513
[TBL] [Abstract][Full Text] [Related]
7. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services.
Dzinamarira T; Moyo E; Dzobo M; Mbunge E; Murewanhema G
Int J Gynecol Cancer; 2023 Apr; 33(4):592-597. PubMed ID: 36368710
[TBL] [Abstract][Full Text] [Related]
9. A population-based combination strategy to improve the cervical cancer screening coverage rate in Bamako, Mali.
Téguété I; Tounkara FK; Diawara B; Traoré S; Koné D; Bagayogo A; Sissoko A; Traoré CB
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):794-801. PubMed ID: 33560520
[TBL] [Abstract][Full Text] [Related]
10. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
[TBL] [Abstract][Full Text] [Related]
11. Integrated Review of Barriers to Cervical Cancer Screening in Sub-Saharan Africa.
McFarland DM; Gueldner SM; Mogobe KD
J Nurs Scholarsh; 2016 Sep; 48(5):490-8. PubMed ID: 27434871
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer: the sub-Saharan African perspective.
Anorlu RI
Reprod Health Matters; 2008 Nov; 16(32):41-9. PubMed ID: 19027621
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening decentralized policy adaptation: an African rural-context-specific systematic literature review.
Rahman R; Clark MD; Collins Z; Traore F; Dioukhane EM; Thiam H; Ndiaye Y; De Jesus EL; Danfakha N; Peters KE; Komarek T; Linn AM; Linn PE; Wallner KE; Charles M; Hasnain M; Peterson CE; Dykens JA
Glob Health Action; 2019; 12(1):1587894. PubMed ID: 30938248
[TBL] [Abstract][Full Text] [Related]
14. Uptake and barriers to cervical cancer screening among human immunodeficiency virus-positive women in Sub Saharan Africa: a systematic review and meta-analysis.
Mengesha MB; Chekole TT; Hidru HD
BMC Womens Health; 2023 Jun; 23(1):338. PubMed ID: 37370091
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening uptake in Sub-Saharan Africa: a systematic review and meta-analysis.
Yimer NB; Mohammed MA; Solomon K; Tadese M; Grutzmacher S; Meikena HK; Alemnew B; Sharew NT; Habtewold TD
Public Health; 2021 Jun; 195():105-111. PubMed ID: 34082174
[TBL] [Abstract][Full Text] [Related]
16. Estimating the costs of cervical cancer screening in high-burden Sub-Saharan African countries.
Mvundura M; Tsu V
Int J Gynaecol Obstet; 2014 Aug; 126(2):151-5. PubMed ID: 24792401
[TBL] [Abstract][Full Text] [Related]
17. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review.
Lim JN; Ojo AA
Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26853214
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: A population-based study.
Ba DM; Ssentongo P; Musa J; Agbese E; Diakite B; Traore CB; Wang S; Maiga M
Cancer Epidemiol; 2021 Jun; 72():101930. PubMed ID: 33756434
[TBL] [Abstract][Full Text] [Related]
19. Global strategies for cervical cancer prevention and screening.
Pimple SA; Mishra GA
Minerva Ginecol; 2019 Aug; 71(4):313-320. PubMed ID: 30808155
[TBL] [Abstract][Full Text] [Related]
20. Adherence to Cervical Cancer Screening Programs in Migrant Populations: A Systematic Review and Meta-Analysis.
Rosato I; Dalla Zuanna T; Tricarico V; Barbiellini Amidei C; Canova C
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
